INVENTIVA SA (IVA.PA) Stock Fundamental Analysis

EPA:IVA • FR0013233012

5.62 EUR
+0.03 (+0.54%)
Last: Feb 20, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership
Fundamental Rating

2

Overall IVA gets a fundamental rating of 2 out of 10. We evaluated IVA against 78 industry peers in the Biotechnology industry. IVA may be in some trouble as it scores bad on both profitability and health. IVA is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

  • In the past year IVA has reported negative net income.
  • In the past year IVA has reported a negative cash flow from operations.
  • In the past 5 years IVA always reported negative net income.
  • IVA had a negative operating cash flow in each of the past 5 years.
IVA.PA Yearly Net Income VS EBIT VS OCF VS FCFIVA.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 -50M -100M -150M

1.2 Ratios

  • IVA's Return On Assets of -173.72% is on the low side compared to the rest of the industry. IVA is outperformed by 84.62% of its industry peers.
Industry RankSector Rank
ROA -173.72%
ROE N/A
ROIC N/A
ROA(3y)-120.12%
ROA(5y)-85.05%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
IVA.PA Yearly ROA, ROE, ROICIVA.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1K 2K 3K

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for IVA so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
IVA.PA Yearly Profit, Operating, Gross MarginsIVA.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 -2K -4K -6K -8K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. Health

2.1 Basic Checks

  • IVA does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for IVA has been increased compared to 1 year ago.
  • IVA has more shares outstanding than it did 5 years ago.
  • IVA has a better debt/assets ratio than last year.
IVA.PA Yearly Shares OutstandingIVA.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
IVA.PA Yearly Total Debt VS Total AssetsIVA.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

  • IVA has an Altman-Z score of -0.31. This is a bad value and indicates that IVA is not financially healthy and even has some risk of bankruptcy.
  • IVA has a Altman-Z score of -0.31. This is comparable to the rest of the industry: IVA outperforms 48.72% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -0.31
ROIC/WACCN/A
WACC8.03%
IVA.PA Yearly LT Debt VS Equity VS FCFIVA.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M -100M

2.3 Liquidity

  • A Current Ratio of 2.96 indicates that IVA has no problem at all paying its short term obligations.
  • With a decent Current ratio value of 2.96, IVA is doing good in the industry, outperforming 61.54% of the companies in the same industry.
  • IVA has a Quick Ratio of 2.96. This indicates that IVA is financially healthy and has no problem in meeting its short term obligations.
  • IVA has a better Quick ratio (2.96) than 66.67% of its industry peers.
Industry RankSector Rank
Current Ratio 2.96
Quick Ratio 2.96
IVA.PA Yearly Current Assets VS Current LiabilitesIVA.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. Growth

3.1 Past

  • The earnings per share for IVA have decreased strongly by -74.11% in the last year.
  • Looking at the last year, IVA shows a very negative growth in Revenue. The Revenue has decreased by -12.84% in the last year.
  • The Revenue has been growing slightly by 5.62% on average over the past years.
EPS 1Y (TTM)-74.11%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-71.33%
Revenue 1Y (TTM)-12.84%
Revenue growth 3Y29.92%
Revenue growth 5Y5.62%
Sales Q2Q%10763.41%

3.2 Future

  • The Earnings Per Share is expected to grow by 13.57% on average over the next years. This is quite good.
  • The Revenue is expected to grow by 109.79% on average over the next years. This is a very strong growth
EPS Next Y45.26%
EPS Next 2Y24.94%
EPS Next 3Y14.52%
EPS Next 5Y13.57%
Revenue Next Year1.86%
Revenue Next 2Y-43.78%
Revenue Next 3Y54.3%
Revenue Next 5Y109.79%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
IVA.PA Yearly Revenue VS EstimatesIVA.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 200M 400M 600M 800M 1B
IVA.PA Yearly EPS VS EstimatesIVA.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 2 -2 4 6

More info and screens

Find the best growth stocksShow best growing peers

0

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for IVA. In the last year negative earnings were reported.
  • Also next year IVA is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
IVA.PA Price Earnings VS Forward Price EarningsIVA.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
IVA.PA Per share dataIVA.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -1 -2 -3

4.3 Compensation for Growth

  • IVA's earnings are expected to grow with 14.52% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y24.94%
EPS Next 3Y14.52%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • IVA does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

INVENTIVA SA

EPA:IVA (2/20/2026, 7:00:00 PM)

5.62

+0.03 (+0.54%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)11-21
Earnings (Next)02-16
Inst Owners43.32%
Inst Owner ChangeN/A
Ins Owners4.97%
Ins Owner ChangeN/A
Market Cap1.16B
Revenue(TTM)13.61M
Net Income(TTM)-310.88M
Analysts88
Price Target13.57 (141.46%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)11.41%
PT rev (3m)16.54%
EPS NQ rev (1m)0%
EPS NQ rev (3m)N/A
EPS NY rev (1m)0.93%
EPS NY rev (3m)10.37%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)19.65%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 85.2
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-3.62
EYN/A
EPS(NY)-0.98
Fwd EYN/A
FCF(TTM)-0.45
FCFYN/A
OCF(TTM)-0.44
OCFYN/A
SpS0.07
BVpS-0.04
TBVpS-0.04
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -173.72%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-120.12%
ROA(5y)-85.05%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.08
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 1.71%
Cap/Sales 0.93%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.96
Quick Ratio 2.96
Altman-Z -0.31
F-Score4
WACC8.03%
ROIC/WACCN/A
Cap/Depr(3y)20.07%
Cap/Depr(5y)N/A
Cap/Sales(3y)3.77%
Cap/Sales(5y)20.51%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-74.11%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-71.33%
EPS Next Y45.26%
EPS Next 2Y24.94%
EPS Next 3Y14.52%
EPS Next 5Y13.57%
Revenue 1Y (TTM)-12.84%
Revenue growth 3Y29.92%
Revenue growth 5Y5.62%
Sales Q2Q%10763.41%
Revenue Next Year1.86%
Revenue Next 2Y-43.78%
Revenue Next 3Y54.3%
Revenue Next 5Y109.79%
EBIT growth 1Y2.1%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year8.14%
EBIT Next 3Y3.93%
EBIT Next 5Y13.49%
FCF growth 1Y-42.56%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-43.45%
OCF growth 3YN/A
OCF growth 5YN/A

INVENTIVA SA / IVA.PA FAQ

What is the ChartMill fundamental rating of INVENTIVA SA (IVA.PA) stock?

ChartMill assigns a fundamental rating of 2 / 10 to IVA.PA.


What is the valuation status for IVA stock?

ChartMill assigns a valuation rating of 0 / 10 to INVENTIVA SA (IVA.PA). This can be considered as Overvalued.


How profitable is INVENTIVA SA (IVA.PA) stock?

INVENTIVA SA (IVA.PA) has a profitability rating of 0 / 10.


How financially healthy is INVENTIVA SA?

The financial health rating of INVENTIVA SA (IVA.PA) is 3 / 10.